药师角色转变、大型并购孕育、药店业务延伸、专业咨询深入和诊所业务的进化都对行业的未来有至关重要的影响。今年夏天,北美药店行业热闹非凡,发生了很多可能会决定行业未来走向的重要事件或新兴苗头。药剂师新角色:专业的仲裁者美国食品药物监督管理局(FDA)未实施任何关于药品仅属于药房类别的管理条例,也就是说,可以卖药的商家不只是药店,还可以是超市、便利店或其它零售组织,但药剂师的介入可能使部分药品从处方药向0TC转换更易接受。因此,作为部分药品从处方药向0TC转换前提的药剂师咨询,可能成为FDA Changes in the role of pharmacist, large mergers and acquisitions, pharmacy business extension, professional counseling in-depth and the evolution of the clinic business have a crucial impact on the future of the industry. This summer, the North American pharmacy industry is bustling with many important events or emerging signs that could determine the future of the industry. Pharmacist New Role: Professional Arbitrator The U.S. Food and Drug Administration (FDA) has not implemented any regulations governing the classification of drugs that fall into the pharmacy category alone. That is, vendors who sell drugs are not just pharmacies, but also supermarkets, conveniences Shop or other retail organization, pharmacists’ interventions may make it more acceptable that some medicines be converted from prescriptions to 0TCs. Therefore, as part of the drug from the prescription drugs to the 0TC conversion prerequisite pharmacist consultation, may become FDA